Paula R. Pohlmann

机构：The University of Texas MD Anderson Cancer Center · ORCID：0000-0001-7914-5162

发表论文 270 篇 · 总被引 4832 次 · h-index 32

代表论文

• Circulating tumor DNA refines risk stratification of neoadjuvant therapy-resistant breast tumors (2025 · Nature Communications · 被引 9)
• Multicenter Interspecialty Consensus on Experimental Oncology Drug–Related Ocular Adverse Event Reporting (2025 · JAMA Ophthalmology · 被引 5)
• Advances in Targeting HER2 across Cancer Subtypes: A Pan-Tumor Approach (2025 · Clinical Cancer Research · 被引 5)
• Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase I Unit (2025 · Cancer Research Communications · 被引 1)
• Disparities in the Surgical Management of the Axilla by Self-Identified Race in the Multicenter Neoadjuvant I-SPY2 Trial (2025 · Annals of Surgical Oncology · 被引 1)
• Abstract LB1-02: MARGOT/TBCRC052: A randomized phase II trial comparing neoadjuvant paclitaxel/margetuximab/pertuzumab (TMP) vs paclitaxel/trastuzumab/pertuzumab (THP) in patients (pts) with stage II-III HER2+ breast cancer (2025 · Clinical Cancer Research · 被引 1)